Table of Contents:

1. Introduction

 1.1 Predictive Biomarkers Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Predictive Biomarkers Market Snapshot

 2.2 Predictive Biomarkers Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Predictive Biomarkers Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Predictive Biomarkers Market Size By Indication

  2.3.2 Predictive Biomarkers Market Size By Technology

  2.3.3 Predictive Biomarkers Market Size By End-user

 2.4 Predictive Biomarkers Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Predictive Biomarkers Market Overview

 3.1 Predictive Biomarkers Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Predictive Biomarkers Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Predictive Biomarkers Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material & Reagent Suppliers

  3.4.2 Biomarker Technology Developers

  3.4.3 Diagnostic Kit Manufacturers

  3.4.4 End Users (Hospitals, Pharma, Research Labs)

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview (Precision Medicine & Molecular Diagnostics)

 3.7 Predictive Biomarkers Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Biomarker Discovery & Validation Trends

  4.1.1 Overview

  4.1.2 Number of Predictive Biomarkers Identified in Oncology Clinical Trials

  4.1.3 Biomarker Validation Success Rate Across Therapeutic Areas

  4.1.4 Integration of Genomics, Proteomics & Transcriptomics in Biomarker Discovery

  4.1.5 Role of AI & Bioinformatics in Predictive Biomarker Identification

4.2 Clinical Adoption & Diagnostic Utilization Metrics

  4.2.1 Overview

  4.2.2 Adoption of Companion Diagnostics in Precision Medicine

  4.2.3 Number of Biomarker-Based Tests Approved by Regulatory Authorities

  4.2.4 Diagnostic Test Utilization Rate in Oncology and Rare Diseases

  4.2.5 Clinical Trial Enrollment Based on Biomarker Stratification

4.3 Regulatory & Compliance Landscape

  4.3.1 Overview

  4.3.2 Regulatory Approval Pathways for Biomarker-Based Diagnostics

  4.3.3 Companion Diagnostic Co-Development with Targeted Therapies

  4.3.4 Reimbursement Policies for Predictive Biomarker Testing

  4.3.5 Global Guidelines for Biomarker Validation and Clinical Implementation

4.4 Technology & Innovation Metrics

  4.4.1 Overview

  4.4.2 Adoption of Next-Generation Sequencing (NGS) Platforms

  4.4.3 Advances in Liquid Biopsy & Non-Invasive Biomarker Detection

  4.4.4 Patent Filings Related to Predictive Biomarker Technologies

  4.4.5 Integration of Multi-Omics Data for Precision Medicine Applications

4.5 Investment & Strategic Activity

  4.5.1 Overview

  4.5.2 Venture Capital Investments in Biomarker Research Companies

  4.5.3 Strategic Collaborations Between Pharma & Diagnostics Companies

  4.5.4 M&A Activity in Biomarker and Precision Medicine Firms

  4.5.5 Expansion of Genomic Research & Clinical Biomarker Programs

5. Predictive Biomarkers Market Segmental Analysis & Forecast, By Indication, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Cancer

  5.2.1 Key Trends

  5.2.2 Predictive Biomarkers Market Size & Forecast, 2022–2035

 5.3 Cardiovascular Diseases

 5.4 Neurological Diseases

 5.5 Immunological Diseases

 5.6 Others

6. Predictive Biomarkers Market Segmental Analysis & Forecast, By Technology, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Diagnostics

  6.2.1 Key Trends

  6.2.2 Predictive Biomarkers Market Size & Forecast, 2022–2035

 6.3 Drug Discovery & Development

 6.4 Personalized Medicine

 6.5 Disease Risk Assessment

 6.6 Others

7. Predictive Biomarkers Market Segmental Analysis & Forecast, By End-user, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Pharmaceutical & Biotechnology Companies

  7.2.1 Key Trends

  7.2.2 Predictive Biomarkers Market Size & Forecast, 2022–2035

 7.3 Diagnostics & Research Laboratories

 7.4 Hospitals & Specialty Clinics

 7.5 Others

8. Predictive Biomarkers Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

8.1 Introduction

8.2 North America

 8.2.1 Key Trends

 8.2.2 Predictive Biomarkers Market Size & Forecast, By Indication, 2022–2035

 8.2.3 Predictive Biomarkers Market Size & Forecast, By Technology, 2022–2035

 8.2.4 Predictive Biomarkers Market Size & Forecast, By End-user, 2022–2035

 8.2.5 Predictive Biomarkers Market Size & Forecast, By Country, 2022–2035

  8.2.5.1 USA

  8.2.5.2 Canada

8.3 Europe

 8.3.1 Key Trends

 8.3.2 Predictive Biomarkers Market Size & Forecast, By Indication, 2022–2035

 8.3.3 Predictive Biomarkers Market Size & Forecast, By Technology, 2022–2035

 8.3.4 Predictive Biomarkers Market Size & Forecast, By End-user, 2022–2035

 8.3.5 Predictive Biomarkers Market Size & Forecast, By Country, 2022–2035

  8.3.5.1 Germany

  8.3.5.2 UK

  8.3.5.3 France

  8.3.5.4 Italy

  8.3.5.5 Spain

  8.3.5.6 Rest of Europe

8.4 Asia-Pacific

 8.4.1 Key Trends

 8.4.2 Predictive Biomarkers Market Size & Forecast, By Indication, 2022–2035

 8.4.3 Predictive Biomarkers Market Size & Forecast, By Technology, 2022–2035

 8.4.4 Predictive Biomarkers Market Size & Forecast, By End-user, 2022–2035

 8.4.5 Predictive Biomarkers Market Size & Forecast, By Country, 2022–2035

  8.4.5.1 China

  8.4.5.2 India

  8.4.5.3 Japan

  8.4.5.4 South Korea

  8.4.5.5 Australia

  8.4.5.6 ASEAN Countries

  8.4.5.7 Rest of Asia-Pacific

8.5 Latin America

 8.5.1 Key Trends

 8.5.2 Predictive Biomarkers Market Size & Forecast, By Indication, 2022–2035

 8.5.3 Predictive Biomarkers Market Size & Forecast, By Technology, 2022–2035

 8.5.4 Predictive Biomarkers Market Size & Forecast, By End-user, 2022–2035

 8.5.5 Predictive Biomarkers Market Size & Forecast, By Country, 2022–2035

  8.5.5.1 Brazil

  8.5.5.2 Mexico

  8.5.5.3 Argentina

  8.5.5.4 Rest of Latin America

8.6 Middle East & Africa

 8.6.1 Key Trends

 8.6.2 Predictive Biomarkers Market Size & Forecast, By Indication, 2022–2035

 8.6.3 Predictive Biomarkers Market Size & Forecast, By Technology, 2022–2035

 8.6.4 Predictive Biomarkers Market Size & Forecast, By End-user, 2022–2035

 8.6.5 Predictive Biomarkers Market Size & Forecast, By Country, 2022–2035

  8.6.5.1 UAE

  8.6.5.2 Saudi Arabia

  8.6.5.3 South Africa

  8.6.5.4 Rest of Middle East & Africa

9. Competitive Landscape

 9.1 Key Players' Positioning

 9.2 Competitive Developments

  9.2.1 Key Strategies Adopted (%), By Key Players, 2025

  9.2.2 Year-Wise Strategies & Development, 2021–2025

  9.2.3 Number Of Strategies Adopted By Key Players, 2025

 9.3 Predictive Biomarkers Market Share Analysis, 2025

 9.4 Product/Service & Application Benchmarking

  9.4.1 Product/Service Specifications & Features By Key Players

  9.4.2 Product/Service Heatmap By Key Players

  9.4.3 Application Heatmap By Key Players

 9.5 Industry Start-Up & Innovation Landscape

9.6 Key Company Profiles

9.6.1 Thermo Fisher Scientific

 9.6.1.1 Company Overview & Snapshot

 9.6.1.2 Product/Service Portfolio

 9.6.1.3 Key Company Financials

 9.6.1.4 SWOT Analysis

9.6.2 Illumina Inc.

9.6.3 Roche Diagnostics

9.6.4 Qiagen N.V.

9.6.5 Agilent Technologies

9.6.6 Bio-Rad Laboratories

9.6.7 PerkinElmer Inc.

9.6.8 Danaher Corporation

9.6.9 Abbott Laboratories

9.6.10 Siemens Healthineers

9.6.11 GE Healthcare

9.6.12 Guardant Health

9.6.13 Foundation Medicine

9.6.14 Exact Sciences Corporation

9.6.15 Myriad Genetics

9.6.16 NeoGenomics Laboratories

9.6.17 BioMérieux

9.6.18 Genomic Health

9.6.19 Tempus Labs

9.6.20 Natera Inc.

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map

 10.2 Industry Low-Hanging Fruit Assessment

 10.3 Predictive Biomarkers Market Entry & Growth Strategy

 10.4 Analyst Viewpoint & Suggestions on Predictive Biomarkers Market Growth

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List Of Tables

 13.2 List Of Figures